注册 | 登录 | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

wbrady5's bayesian [16 articles]

当前文献位于 wbrady5's 文献库 标签分类为 bayesian. You can also see everyone's bayesian.
  • Can external and subjective information ever be used to reduce the size of randomised controlled trials?
    Contemporary Clinical Trials, Vol. 29, No. 2. (March 2008), pp. 211-219.
    by Say-Beng Tan, Joseph Wee, Hwee-Bee Wong, David Machin
    posted to bayesian clinical_trial rare_tumors by wbrady5 on 2008-03-05 16:32:47 as ** along with 1 person jyuh
  • A Bayesian evaluation of enrolling additional patients at the maximum tolerated dose in Phase I trials
    Contemporary Clinical Trials, Vol. 26, No. 2. (April 2005), pp. 131-140.
    by Mithat Gonen
    posted to bayesian phase_i by wbrady5 on 2008-02-26 02:28:35 as **
  • Theory and Practice of Bayesian Statistics
    by Dennis V Lindley
    posted to bayesian by wbrady5 on 2008-01-17 13:35:58 as ** along with 1 person and 1 group rlai MITCCI
  • Data Monitoring Committees and Interim Monitoring Guidelines
    Controlled Clinical Trials, Vol. 20, No. 5. (October 1999), pp. 395-407.
    by Boris Freidlin, Edward L Korn, Stephen L George
    posted to bayesian clinical_trial interim_analysis sequential stochastic_curtailment by wbrady5 on 2008-01-16 15:34:07 as **
  • Practical Bayesian Guidelines for Phase IIB Clinical Trials
    Biometrics, Vol. 50, No. 2. (1994), pp. 337-349.
    by Peter F Thall, Richard Simon
    posted to bayesian clinical_trial phase_ii by wbrady5 on 2008-01-10 18:23:33 as **
  • Rejoinder: The new adversary
    Statistics in Medicine, Vol. 27, No. 4. (2008), pp. 488-489.
    by Lemuel A Moyé
    posted to bayesian clinical_trial by wbrady5 on 2008-01-10 15:23:33 as **
  • Comments on ?Bayesians in clinical trials: Asleep at the switch? by Lemuel A. Moyé, <I>Statistics in Medicine</I>
    Statistics in Medicine, Vol. 27, No. 4. (2008), pp. 483-487.
    by Kathryn Chaloner
    posted to bayesian clinical_trial by wbrady5 on 2008-01-10 15:23:08 as read
  • Bayesians in clinical trials: Asleep at the switch.
    Stat Med (15 June 2007)
    by Lemuel A A Moyé
    posted to bayesian clinical_trial by wbrady5 on 2008-01-10 15:15:06 as read along with 2 people jyuh Borelli
  • Two-Dimensional Dose Finding in Discrete Dose Space
    Biometrics, Vol. 61, No. 1. (March 2005), pp. 217-222.
    by Kai Wang, Anastasia Ivanova
    posted to bayesian combination_therapy continual_reassessment_method phase_i by wbrady5 on 2008-01-04 22:05:21 as **
  • A Parallel Phase III Clinical Trial Design for Combination Therapies
    Biometrics, Vol. 63, No. 2. (June 2007), pp. 429-436.
    by Huang, Xuelin, Biswas, Swati, Oki, Yasuhiro, Issa, Jean-Pierre, Berry, A Donald
    posted to bayesian bivariate clinical_trial combination_therapy phase_i phase_ii toxicity by wbrady5 on 2008-01-04 21:59:15 as **
  • Bayesian Dose-Finding in Phase III Clinical Trials Using Toxicity and Efficacy Odds Ratios
    Biometrics, Vol. 62, No. 3. (September 2006), pp. 777-787.
    by Yin, Guosheng, Li, Yisheng, Ji, Yuan
    posted to adaptive bayesian bivariate clinical_trial phase_i by wbrady5 on 2008-01-04 21:51:07 as **
  • A Bayesian Approach to Jointly Modeling Toxicity and Biomarker Expression in a Phase I/II Dose-Finding Trial
    Biometrics, Vol. 61, No. 2. (June 2005), pp. 343-354.
    by B Nebiyou, Yu Shen
    posted to bayesian biomarker clinical_trial phase_i phase_ii toxicity by wbrady5 on 2008-01-04 21:46:56 as **
  • Bayesian Optimal Designs for Phase I Clinical Trials
    Biometrics, Vol. 59, No. 3. (2003), pp. 591-600.
    by Linda M Haines, Inna Perevozskaya, William F Rosenberger
    posted to bayesian clinical_trial optimal_design phase_i by wbrady5 on 2008-01-04 21:33:54 as **
  • Dose-Finding with Two Agents in Phase I Oncology Trials
    Biometrics, Vol. 59, No. 3. (2003), pp. 487-496.
    by Peter F Thall, Randall E Millikan, Peter Mueller, Sang J Lee
    posted to bayesian clinical_trial combination_therapy phase_i toxicity by wbrady5 on 2008-01-04 21:31:11 as read
  • Adaptive Dose Selection Using Efficacy-Toxicity Trade-Offs: Illustrations and Practical Considerations
    Journal of Biopharmaceutical Statistics, Vol. 16, No. 5. (2006), pp. 623-638.
    by Peter F Thall, John D Cook, Elihu H Estey
    posted to bayesian bivariate clinical_trial continual_reassessment_method phase_i by wbrady5 on 2008-01-02 22:12:27 as **
  • An Evaluation of a Bayesian Method of Dose Escalation Based on Bivariate Binary Responses
    Journal of Biopharmaceutical Statistics, Vol. 14, No. 4. (2004), pp. 969-983.
    by John Whitehead, Yinghui Zhou, John Stevens, Graham Blakey
    posted to bayesian bivariate continual_reassessment_method phase_i by wbrady5 on 2008-01-02 22:09:55 as **
    • ◇温馨提示◇本页的引用地址为： http://www.citeulike.org/user/wbrady5/tag/bayesian

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.